Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient

Journal of Neurosurgery: Spine

Volumn 21, Issue 4, 2014, Pages 618-622

  Dlouhy, Brian J ^a   Awe, Olatilewa ^a   Rao, Rajesh C ^b   Kirby, Patricia A ^a   Hitchon, Patrick W ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell transplantation; Human; Olfactory ensheathing cells; Olfactory mucosa; Oncology; Spinal cord injury; Stem cells; Tumor

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN S 100;

ADULT; ARTICLE; AUTOGRAFT; CASE REPORT; CELL TRANSPLANTATION; CYST; DISEASE DURATION; DISLOCATION; ENDOSCOPY; FEMALE; GOBLET CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INJURY SEVERITY; LAMINECTOMY; LOW BACK PAIN; MOTOR PERFORMANCE; NEURAL STEM CELL TRANSPLANTATION; NEUROFILAMENT; OLFACTORY EPITHELIUM; OLFACTORY MUCOSAL CELL TRANSPLANTATION; PARAPLEGIA; PEROPERATIVE CARE; RESPIRATORY EPITHELIUM; SCAR; SPINAL CORD DISEASE; SPINAL CORD INJURY; SPINAL CORD MASS; TRAFFIC ACCIDENT; ADOLESCENT; CHORISTOMA; CYSTS; CYTOLOGY; PATHOLOGY; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; VERTEBRA;

ACCIDENTS, TRAFFIC; ADOLESCENT; AUTOGRAFTS; CHORISTOMA; CYSTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; OLFACTORY MUCOSA; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; THORACIC VERTEBRAE;

EID: 84907862127     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2014.5.SPINE13992     Document Type: Article

References (14)

1. Amariglio N, Hirshberg A, Scheithauer BW, Cohen Y, Loewenthal R, Trakhtenbrot L, et al: Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6:e1000029, 2009.
2. Granger N, Blamires H, Franklin RJ, Jeffery ND: Autologous olfactory mucosal cell transplants in clinical spinal cord injury: A randomized double-blinded trial in a canine translational model. Brain 135:3227-3237, 2012.
3. Greaves MF: Cord blood donor cell leukemia in recipients. Leukemia 20:1633-1634, 2006.
4. Li Y, Field PM, Raisman G: Regeneration of adult rat corticospinal axons induced by transplanted olfactory ensheathing cells. J Neurosci 18:10514-10524, 1998.
5. Lima C, Escada P, Pratas-Vital J, Branco C, Arcangeli CA, Lazzeri G, et al: Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair 24:10-22, 2010.
6. Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD: Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J Spinal Cord Med 29:191-206, 2006.
7. Lindvall O, Barker RA, Brüstle O, Isacson O, Svendsen CN: Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell 10:151-155, 2012.
8. Lindvall O, Kokaia Z: Stem cells in human neurodegenerative disorders-time for clinical translation? J Clin Invest 120:29-40, 2010.
9. Lindvall O, Kokaia Z, Martinez-Serrano A: Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 10 Suppl:S42-S50, 2004.
10. Lu J, Féron F, Mackay-Sim A, Waite PM: Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain 125:14-21, 2002.
11. Mackay-Sim A, Féron F, Cochrane J, Bassingthwaighte L, Bayliss C, Davies W, et al: Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain 131:2376-2386, 2008.
12. Murrell W, Wetzig A, Donnellan M, Féron F, Burne T, Meedeniya A, et al: Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Stem Cells 26:2183-2192, 2008.
13. Nakamura M, Okano H: Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res 23:70-80, 2013.
14. Riley J, Glass J, Feldman EL, Polak M, Bordeau J, Federici T, et al: Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: A phase I trial, cervical microinjection and final surgical safety outcomes. Neurosurgery 74:77-87, 2014.